Cargando…
T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients
INTRODUCTION: This study aimed to identify markers of disease worsening in patients hospitalized for SARS-Cov2 infection. PATIENTS AND METHODS: Patients hospitalized for severe recent-onset (<1 week) SARS-Cov2 infection were prospectively included. The percentage of T-cell subsets and plasma IL-6...
Autores principales: | Samson, Maxime, Nicolas, Barbara, Ciudad, Marion, Greigert, Hélène, Guilhem, Alexandre, Cladiere, Claudie, Straub, Cécile, Blot, Mathieu, Piroth, Lionel, Rogier, Thomas, Devilliers, Hervé, Manckoundia, Patrick, Ghesquiere, Thibault, Francois, Stéphanie, Lakomy, Daniela, Audia, Sylvain, Bonnotte, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163020/ https://www.ncbi.nlm.nih.gov/pubmed/35690570 http://dx.doi.org/10.1016/j.ejim.2022.06.001 |
Ejemplares similares
-
L’augmentation du pourcentage de lymphocytes Th17 est associée à un risque d’évolution vers une forme grave d’infection à SARS-CoV-2
por: Samson, M., et al.
Publicado: (2022) -
Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect
por: Janikashvili, Nona, et al.
Publicado: (2021) -
Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD
por: Gérard, Claire, et al.
Publicado: (2022) -
Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis
por: Samson, Maxime, et al.
Publicado: (2021) -
Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis
por: Samson, Maxime, et al.
Publicado: (2023)